Recent advances in nonviral vectors for gene delivery.
Recent advances in nonviral vectors for gene delivery.
复制标题
DOI:
10.1021/ar200151m
复制
发表时间:
2012-07-17
影响因子:
18.3
通讯作者:
Huang, Leaf
中科院分区:
文献类型:
--
作者:
Guo, Xia;Huang, Leaf
Non-viral vectors, typically based on cationic lipids or polymers, are preferred due to safety concerns with viral vectors. So far, non-viral vectors can proficiently transfect cells in culture, but obtaining efficient nanomedicines is far from evident. To overcome the hurdles associated with non-viral vectors is significant for improving delivery efficiency and therapeutic effect of nucleic acid. The drawbacks include the strong interaction of cationic delivery vehicles with blood components, uptake by the reticuloendothelial system (RES), toxicity, targeting ability of the carriers to the cells of interest, and so on. PEGylation is the predominant method used to reduce the binding of plasma proteins with non-viral vectors and minimize the clearance by RES after intravenous administration. The nanoparticles that are not rapidly cleared from the circulation accumulate in the tumors due to the enhanced permeability and retention effect, and the targeting ligands attached to the distal end of the PEGylated components allow binding to the receptors on the target cell surface. Neutral or anionic liposomes have been also developed for systemic delivery of nucleic acids in experimental animal model. Designing and synthesizing novel cationic lipids and polymers, and binding nucleic acid with peptides, targeting ligands, polymers, or environmentally sensitive moieties also attract many attentions for resolving the problems encountered by non-viral vectors. The application of inorganic nanoparticles in nucleic acid delivery is an emerging field, too. Recently, different classes of non-viral vectors appear to be converging and the features of different classes of non-viral vectors could be combined in one strategy. More hurdles associated with efficient nucleic acid delivery therefore might be expected to be overcome. In this account, we will focus on these novel non-viral vectors, which are classified into multifunctional hybrid nucleic acid vectors, novel membrane/core nanoparticles for nucleic acid delivery and ultrasound-responsive nucleic acid vectors. The systemic delivery studies are highlighted. Finally, we bring forward the prospect for nucleic acid delivery. We think a better understandings of the fate of the nanoparticles inside the cell and of the interactions between the parts of hybrid particles will lead to a delivery system suitable for clinical use. We also underscore the value of sustained release of nucleic acid and presume making vectors targeted to cells with sustained release in vivo should be an interesting research challenge.
登录
查看更多内容
影响因子:
4.9
作者:
Kulltarni, Mangesh M.;Greiser, Udo;Pandit, Abhay
通讯作者:
Pandit, Abhay
影响因子:
17.1
作者:
Li C;Penet MF;Wildes F;Takagi T;Chen Z;Winnard PT;Artemov D;Bhujwalla ZM
通讯作者:
Bhujwalla ZM
影响因子:
2.9
作者:
Carson, Andrew R.;McTiernan, Charles F.;Lavery, Linda;Hodnick, Abigail;Grata, Michelle;Leng, Xiaoping;Wang, Jianjun;Chen, Xucai;Modzelewski, Ruth A.;Villanueva, Flordeliza S.
通讯作者:
Villanueva, Flordeliza S.
影响因子:
4.8
作者:
Chen, Yunching;Bathula, Surendar Reddy;Huang, Leaf
通讯作者:
Huang, Leaf
影响因子:
10.8
作者:
Li, Shyh-Dar;Chono, Sumio;Huang, Leaf
通讯作者:
Huang, Leaf